676371-65-6

Basic information

• Product Name: Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-aMino-, Methyl ester, hydrochloride (9CI)
• Synonyms: Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-aMino-, Methyl ester, hydrochloride (9CI);Methyl 3-aminobicyclo[1.1.1]pentane-1-carboxylate hydrochloride;Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-aMino-, Methyl ester, hydrochloride;3-Amino-bicyclo[1.1.1]pentane-1-carboxylic acid methyl ester hydrochloride;METHYL 3-AMINOBICYCLO[1.1.1]PENTANE-1-CARBOXYLATE HCL
• CAS NO: 676371-65-6
• Molecular Formula: C7H12ClNO2
• Molecular Weight: 177.62868
• EINECS: -0
• Mol File: 676371-65-6.mol
• Article Data: 0

Chemical Properties

• Melting Point: 209 °C (decomp)(Solv: methanol (67-56-1))
• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-aMino-, Methyl ester, hydrochloride (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-aMino-, Methyl ester, hydrochloride (9CI)(676371-65-6)
• EPA Substance Registry System: Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-aMino-, Methyl ester, hydrochloride (9CI)(676371-65-6)

Safety Data

• Hazardous Substances Data: 676371-65-6(Hazardous Substances Data)

Usage

Description

Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-aMino-, Methyl ester, hydrochloride (9CI), also known as Methyl 3-Aminobicyclo[1.1.1]pentane-1-carboxylate Hydrochloride, is a chemical compound with a unique bicyclic structure and an amino group. It is characterized by its ability to form a methyl ester and its reactivity with hydrochloric acid, resulting in the formation of a hydrochloride salt.

Uses

Used in Pharmaceutical Industry:
Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-aMino-, Methyl ester, hydrochloride (9CI) is used as a BRD9 inhibitor for the development of drugs targeting cancer or viral infections. Its unique structure and functional groups allow it to interact with specific biological targets, making it a promising candidate for the treatment of various diseases.
In the development of cancer therapeutics, this compound can be utilized to inhibit the bromodomain and extra-terminal domain protein 9 (BRD9), which plays a crucial role in the regulation of gene expression and cell cycle progression. By targeting BRD9, this compound has the potential to disrupt the growth and survival of cancer cells, offering a new avenue for cancer treatment.
In the context of viral infections, the compound may also exhibit antiviral properties by targeting specific viral proteins or pathways, thereby inhibiting viral replication and reducing the severity of the infection.
Overall, Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-aMino-, Methyl ester, hydrochloride (9CI) holds significant potential in the pharmaceutical industry as a BRD9 inhibitor, offering new opportunities for the development of innovative treatments for cancer and viral infections.